-
Butyrate Induces Ferroptosis in Lung Cancer Stem Cells via L
2026-07-17
This study demonstrates that butyrate attenuates stemness in lung cancer stem cells by promoting ferroptosis via lysosomal Fe2+ accumulation and SLC7A11 protein degradation. The findings highlight a novel mechanism linking metabolic regulation to targeted cancer therapy and suggest new avenues for disrupting cancer stem cell resilience.
-
Brefeldin A in Advanced ER Stress and Cancer Cell Assays
2026-07-16
Brefeldin A (BFA) is a gold-standard tool for dissecting ER stress, vesicle trafficking, and apoptosis in cancer research. This article delivers actionable protocols, experimental troubleshooting, and expert insight into leveraging BFA’s mechanistic precision for high-impact studies.
-
SLC2A5-Driven Fructose Metabolism as a Target in PCNS Lympho
2026-07-16
This study uses single-cell multi-omics to reveal that primary CNS lymphoma (PCNSL) exploits SLC2A5-mediated fructose metabolism in response to a hypoxic, glucose-depleted tumor microenvironment. The findings highlight a metabolic vulnerability that may inform new therapeutic strategies and underscore the importance of precise immunoassay tools for research in complex CNS tissues.
-
Amplex Red: Precision ROS Detection and ATX Inhibitor Assays
2026-07-15
Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) enables ultrasensitive, high-throughput detection of hydrogen peroxide and peroxidase activity, revolutionizing workflows in redox biology and drug discovery. APExBIO’s high-purity Amplex Red empowers robust oxidative stress and NADPH oxidase activity assays, while the reference protocol introduces reproducible, interference-minimized strategies for screening autotaxin inhibitors.
-
Cell lysis buffer for WB and IP: Optimizing Native Protein E
2026-07-15
Unlock reproducible, high-yield protein extraction across diverse tissues and cells with a non-denaturing buffer fortified by a robust protease and phosphatase inhibitor cocktail. This guide translates recent tumor microenvironment research into actionable workflows, advanced troubleshooting, and protocol enhancements for Western blot and immunoprecipitation.
-
RIPA Lysis Buffer Strong: Precision Protein Extraction for T
2026-07-14
Discover how RIPA Lysis Buffer Strong enables precise, customizable protein extraction for advanced oncology research. This article explores its unique advantages, protocol strategies, and deep scientific context, setting it apart as a cornerstone for translational assay workflows.
-
CAFs Drive Chemoresistance in Prostate Cancer via ANGPTL4-IQ
2026-07-14
This study reveals that cancer-associated fibroblasts (CAFs) promote chemoresistance in prostate cancer by enhancing mitochondrial activity through the ANGPTL4-IQGAP1 axis. Proteomic, metabolic, and functional analyses highlight new therapeutic targets and offer insights for overcoming drug resistance.
-
PARP1/FAK/COL5A1 Axis Drives EMT in Cholesterol-Resistant Ov
2026-07-13
This study reveals that persistent high cholesterol induces tumorigenesis in ovarian cancer via activation of the PARP1/FAK/COL5A1 signaling axis, which drives epithelial-mesenchymal transition (EMT). These findings clarify a mechanistic link between cholesterol resistance and metastatic potential, suggesting new intervention points for advanced ovarian cancer research.
-
Palonosetron Hydrochloride in CINV/RINV: Clinical Innovation
2026-07-13
The referenced review by Fabi and Malaguti synthesizes clinical and mechanistic evidence on palonosetron hydrochloride, a next-generation 5-HT3 receptor antagonist, highlighting its superior efficacy in preventing both acute and delayed chemotherapy- and radiotherapy-induced nausea and vomiting (CINV/RINV). The study underscores palonosetron's distinct pharmacokinetic and pharmacodynamic properties, informing its central position in antiemetic guidelines and translational research.
-
Lipid Scrambling by TMEM16F Regulates Ferroptosis and Tumor
2026-07-12
This study uncovers TMEM16F-mediated lipid scrambling as a critical suppressor of ferroptosis at the plasma membrane. The findings reveal that targeting TMEM16F enhances ferroptotic cell death and synergizes with immunotherapy, suggesting new strategies for cancer treatment.
-
Obeticholic Acid (6-ECDCA, INT-747): Reliable Tools for Live
2026-07-10
This article delivers scenario-driven guidance for leveraging Obeticholic Acid (6alpha-ethyl-chenodeoxycholic acid, 6-ECDCA, INT-747; SKU B4888) in cell-based liver fibrosis assays. It addresses reproducibility, protocol optimization, and vendor selection—grounded in quantitative evidence and APExBIO's product specifications—to support biomedical researchers in achieving robust and interpretable results.
-
Necrosulfonamide: Deciphering Necroptosis Beyond Assays
2026-07-09
Explore how Necrosulfonamide (NSA) enables advanced dissection of necroptotic pathways, bridging mechanistic insight and translational research. This article uniquely analyzes NSA’s specificity and utility in context of cutting-edge findings in cardiovascular necroptosis.
-
gamma-Glu-Cys (γ-Glu-Cys): Technical Guide for Lab Research
2026-07-09
gamma-Glu-Cys (γ-Glu-Cys) is a high-purity substrate essential for workflows involving glutathione metabolism, thiol-reactive peptide synthesis, and plant stress adaptation studies. It is not suited for diagnostic or therapeutic applications, and long-term solution storage should be avoided to maintain performance. This guide provides actionable parameters and workflow recommendations for research use.
-
RIPA Lysis Buffer (Strong, without inhibitors): Technical Gu
2026-07-08
RIPA Lysis Buffer (Strong, without inhibitors) enables efficient and flexible protein extraction from animal cells and tissues, particularly where custom inhibitor supplementation is required. It is not suitable for workflows requiring intrinsic protease or phosphatase protection, and users must add inhibitors as needed for sensitive applications.
-
Cell lysis buffer for WB and IP: Mechanism, Evidence, and Pi
2026-07-08
Cell lysis buffer for WB and IP enables efficient, non-denaturing protein extraction for Western blot and immunoprecipitation. Its optimized protease and phosphatase inhibitor cocktail preserves protein complexes, supporting reliable downstream analysis. This article details its validated composition, mechanistic rationale, and key limitations, referencing both recent tumor microenvironment research and product specifications.